 | • レポートコード：MRC308GR11376 • 出版社/出版日：GlobalInfoResearch / 2023年8月 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医薬品＆ヘルスケア |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
GlobalInfoResearchの最新の調査によると、世界のシクロホスファミド薬の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界のシクロホスファミド薬市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。
市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。
本レポートの主な目的は次のとおりです。
– 世界および主要国の市場機会の規模を決定するため
– シクロホスファミド薬の成長可能性を評価するため
– 各製品および最終用途市場の将来の成長を予測するため
– 市場に影響を与える競争要因を評価するため
シクロホスファミド薬市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。
種類別セグメント
・経口、非経口
用途別セグメント
・クリニック、病院、その他
主要な市場プレーヤー
・Baxter Laboratories Ltd.、Novartis AG、Himka Pharmaceuticals Plc.、Amneal Pharmaceuticals LLC、NorthStar Rx LLC、Aurobindo Pharma Ltd.、CSC Pharmaceutical International、Jiangsu Hengrui Medicine Co Ltd、Nodus Oncology、Abbive, Inc.、Theravance Biopharm, Inc.、Sanofi S.A.、Roxane Laboratories Pvt Ltd、LGM Pharma Llc
地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）
本調査レポートの内容は計15章あります。
・第1章では、シクロホスファミド薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なシクロホスファミド薬メーカーの企業概要、2019年～2022年までのシクロホスファミド薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なシクロホスファミド薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別シクロホスファミド薬の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までのシクロホスファミド薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域でのシクロホスファミド薬市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、およびシクロホスファミド薬の産業チェーンを掲載しています。
・第14、15章では、シクロホスファミド薬の販売チャネル、販売業者、顧客、調査結果について説明します。
***** 目次(一部) *****
・市場概要
– シクロホスファミド薬の概要
– 種類別分析（2018年vs2022年vs2029年）：経口、非経口
– 用途別分析（2018年vs2022年vs2029年）：クリニック、病院、その他
– 世界のシクロホスファミド薬市場規模・予測
– 世界のシクロホスファミド薬生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Baxter Laboratories Ltd.、Novartis AG、Himka Pharmaceuticals Plc.、Amneal Pharmaceuticals LLC、NorthStar Rx LLC、Aurobindo Pharma Ltd.、CSC Pharmaceutical International、Jiangsu Hengrui Medicine Co Ltd、Nodus Oncology、Abbive, Inc.、Theravance Biopharm, Inc.、Sanofi S.A.、Roxane Laboratories Pvt Ltd、LGM Pharma Llc
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：経口、非経口
・用途別分析2018年-2029年：クリニック、病院、その他
・シクロホスファミド薬の北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・シクロホスファミド薬のヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・シクロホスファミド薬のアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・シクロホスファミド薬の南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・シクロホスファミド薬の中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
1 Market Overview
1.1 Product Overview and Scope of Cyclophosphamide Drug
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Cyclophosphamide Drug Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Oral
1.3.3 Parenteral
1.4 Market Analysis by Application
1.4.1 Overview: Global Cyclophosphamide Drug Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Clinic
1.4.3 Hospital
1.4.4 Others
1.5 Global Cyclophosphamide Drug Market Size & Forecast
1.5.1 Global Cyclophosphamide Drug Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Cyclophosphamide Drug Sales Quantity (2018-2029)
1.5.3 Global Cyclophosphamide Drug Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Baxter Laboratories Ltd.
2.1.1 Baxter Laboratories Ltd. Details
2.1.2 Baxter Laboratories Ltd. Major Business
2.1.3 Baxter Laboratories Ltd. Cyclophosphamide Drug Product and Services
2.1.4 Baxter Laboratories Ltd. Cyclophosphamide Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Baxter Laboratories Ltd. Recent Developments/Updates
2.2 Novartis AG
2.2.1 Novartis AG Details
2.2.2 Novartis AG Major Business
2.2.3 Novartis AG Cyclophosphamide Drug Product and Services
2.2.4 Novartis AG Cyclophosphamide Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Novartis AG Recent Developments/Updates
2.3 Himka Pharmaceuticals Plc.
2.3.1 Himka Pharmaceuticals Plc. Details
2.3.2 Himka Pharmaceuticals Plc. Major Business
2.3.3 Himka Pharmaceuticals Plc. Cyclophosphamide Drug Product and Services
2.3.4 Himka Pharmaceuticals Plc. Cyclophosphamide Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Himka Pharmaceuticals Plc. Recent Developments/Updates
2.4 Amneal Pharmaceuticals LLC
2.4.1 Amneal Pharmaceuticals LLC Details
2.4.2 Amneal Pharmaceuticals LLC Major Business
2.4.3 Amneal Pharmaceuticals LLC Cyclophosphamide Drug Product and Services
2.4.4 Amneal Pharmaceuticals LLC Cyclophosphamide Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Amneal Pharmaceuticals LLC Recent Developments/Updates
2.5 NorthStar Rx LLC
2.5.1 NorthStar Rx LLC Details
2.5.2 NorthStar Rx LLC Major Business
2.5.3 NorthStar Rx LLC Cyclophosphamide Drug Product and Services
2.5.4 NorthStar Rx LLC Cyclophosphamide Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 NorthStar Rx LLC Recent Developments/Updates
2.6 Aurobindo Pharma Ltd.
2.6.1 Aurobindo Pharma Ltd. Details
2.6.2 Aurobindo Pharma Ltd. Major Business
2.6.3 Aurobindo Pharma Ltd. Cyclophosphamide Drug Product and Services
2.6.4 Aurobindo Pharma Ltd. Cyclophosphamide Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Aurobindo Pharma Ltd. Recent Developments/Updates
2.7 CSC Pharmaceutical International
2.7.1 CSC Pharmaceutical International Details
2.7.2 CSC Pharmaceutical International Major Business
2.7.3 CSC Pharmaceutical International Cyclophosphamide Drug Product and Services
2.7.4 CSC Pharmaceutical International Cyclophosphamide Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 CSC Pharmaceutical International Recent Developments/Updates
2.8 Jiangsu Hengrui Medicine Co Ltd
2.8.1 Jiangsu Hengrui Medicine Co Ltd Details
2.8.2 Jiangsu Hengrui Medicine Co Ltd Major Business
2.8.3 Jiangsu Hengrui Medicine Co Ltd Cyclophosphamide Drug Product and Services
2.8.4 Jiangsu Hengrui Medicine Co Ltd Cyclophosphamide Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Jiangsu Hengrui Medicine Co Ltd Recent Developments/Updates
2.9 Nodus Oncology
2.9.1 Nodus Oncology Details
2.9.2 Nodus Oncology Major Business
2.9.3 Nodus Oncology Cyclophosphamide Drug Product and Services
2.9.4 Nodus Oncology Cyclophosphamide Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Nodus Oncology Recent Developments/Updates
2.10 Abbive, Inc.
2.10.1 Abbive, Inc. Details
2.10.2 Abbive, Inc. Major Business
2.10.3 Abbive, Inc. Cyclophosphamide Drug Product and Services
2.10.4 Abbive, Inc. Cyclophosphamide Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Abbive, Inc. Recent Developments/Updates
2.11 Theravance Biopharm, Inc.
2.11.1 Theravance Biopharm, Inc. Details
2.11.2 Theravance Biopharm, Inc. Major Business
2.11.3 Theravance Biopharm, Inc. Cyclophosphamide Drug Product and Services
2.11.4 Theravance Biopharm, Inc. Cyclophosphamide Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Theravance Biopharm, Inc. Recent Developments/Updates
2.12 Sanofi S.A.
2.12.1 Sanofi S.A. Details
2.12.2 Sanofi S.A. Major Business
2.12.3 Sanofi S.A. Cyclophosphamide Drug Product and Services
2.12.4 Sanofi S.A. Cyclophosphamide Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Sanofi S.A. Recent Developments/Updates
2.13 Roxane Laboratories Pvt Ltd
2.13.1 Roxane Laboratories Pvt Ltd Details
2.13.2 Roxane Laboratories Pvt Ltd Major Business
2.13.3 Roxane Laboratories Pvt Ltd Cyclophosphamide Drug Product and Services
2.13.4 Roxane Laboratories Pvt Ltd Cyclophosphamide Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Roxane Laboratories Pvt Ltd Recent Developments/Updates
2.14 LGM Pharma Llc
2.14.1 LGM Pharma Llc Details
2.14.2 LGM Pharma Llc Major Business
2.14.3 LGM Pharma Llc Cyclophosphamide Drug Product and Services
2.14.4 LGM Pharma Llc Cyclophosphamide Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 LGM Pharma Llc Recent Developments/Updates
3 Competitive Environment: Cyclophosphamide Drug by Manufacturer
3.1 Global Cyclophosphamide Drug Sales Quantity by Manufacturer (2018-2023)
3.2 Global Cyclophosphamide Drug Revenue by Manufacturer (2018-2023)
3.3 Global Cyclophosphamide Drug Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Cyclophosphamide Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Cyclophosphamide Drug Manufacturer Market Share in 2022
3.4.2 Top 6 Cyclophosphamide Drug Manufacturer Market Share in 2022
3.5 Cyclophosphamide Drug Market: Overall Company Footprint Analysis
3.5.1 Cyclophosphamide Drug Market: Region Footprint
3.5.2 Cyclophosphamide Drug Market: Company Product Type Footprint
3.5.3 Cyclophosphamide Drug Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Cyclophosphamide Drug Market Size by Region
4.1.1 Global Cyclophosphamide Drug Sales Quantity by Region (2018-2029)
4.1.2 Global Cyclophosphamide Drug Consumption Value by Region (2018-2029)
4.1.3 Global Cyclophosphamide Drug Average Price by Region (2018-2029)
4.2 North America Cyclophosphamide Drug Consumption Value (2018-2029)
4.3 Europe Cyclophosphamide Drug Consumption Value (2018-2029)
4.4 Asia-Pacific Cyclophosphamide Drug Consumption Value (2018-2029)
4.5 South America Cyclophosphamide Drug Consumption Value (2018-2029)
4.6 Middle East and Africa Cyclophosphamide Drug Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Cyclophosphamide Drug Sales Quantity by Type (2018-2029)
5.2 Global Cyclophosphamide Drug Consumption Value by Type (2018-2029)
5.3 Global Cyclophosphamide Drug Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Cyclophosphamide Drug Sales Quantity by Application (2018-2029)
6.2 Global Cyclophosphamide Drug Consumption Value by Application (2018-2029)
6.3 Global Cyclophosphamide Drug Average Price by Application (2018-2029)
7 North America
7.1 North America Cyclophosphamide Drug Sales Quantity by Type (2018-2029)
7.2 North America Cyclophosphamide Drug Sales Quantity by Application (2018-2029)
7.3 North America Cyclophosphamide Drug Market Size by Country
7.3.1 North America Cyclophosphamide Drug Sales Quantity by Country (2018-2029)
7.3.2 North America Cyclophosphamide Drug Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Cyclophosphamide Drug Sales Quantity by Type (2018-2029)
8.2 Europe Cyclophosphamide Drug Sales Quantity by Application (2018-2029)
8.3 Europe Cyclophosphamide Drug Market Size by Country
8.3.1 Europe Cyclophosphamide Drug Sales Quantity by Country (2018-2029)
8.3.2 Europe Cyclophosphamide Drug Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Cyclophosphamide Drug Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Cyclophosphamide Drug Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Cyclophosphamide Drug Market Size by Region
9.3.1 Asia-Pacific Cyclophosphamide Drug Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Cyclophosphamide Drug Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Cyclophosphamide Drug Sales Quantity by Type (2018-2029)
10.2 South America Cyclophosphamide Drug Sales Quantity by Application (2018-2029)
10.3 South America Cyclophosphamide Drug Market Size by Country
10.3.1 South America Cyclophosphamide Drug Sales Quantity by Country (2018-2029)
10.3.2 South America Cyclophosphamide Drug Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Cyclophosphamide Drug Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Cyclophosphamide Drug Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Cyclophosphamide Drug Market Size by Country
11.3.1 Middle East & Africa Cyclophosphamide Drug Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Cyclophosphamide Drug Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Cyclophosphamide Drug Market Drivers
12.2 Cyclophosphamide Drug Market Restraints
12.3 Cyclophosphamide Drug Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Cyclophosphamide Drug and Key Manufacturers
13.2 Manufacturing Costs Percentage of Cyclophosphamide Drug
13.3 Cyclophosphamide Drug Production Process
13.4 Cyclophosphamide Drug Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Cyclophosphamide Drug Typical Distributors
14.3 Cyclophosphamide Drug Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table 1. Global Cyclophosphamide Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Cyclophosphamide Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Baxter Laboratories Ltd. Basic Information, Manufacturing Base and Competitors
Table 4. Baxter Laboratories Ltd. Major Business
Table 5. Baxter Laboratories Ltd. Cyclophosphamide Drug Product and Services
Table 6. Baxter Laboratories Ltd. Cyclophosphamide Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Baxter Laboratories Ltd. Recent Developments/Updates
Table 8. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 9. Novartis AG Major Business
Table 10. Novartis AG Cyclophosphamide Drug Product and Services
Table 11. Novartis AG Cyclophosphamide Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Novartis AG Recent Developments/Updates
Table 13. Himka Pharmaceuticals Plc. Basic Information, Manufacturing Base and Competitors
Table 14. Himka Pharmaceuticals Plc. Major Business
Table 15. Himka Pharmaceuticals Plc. Cyclophosphamide Drug Product and Services
Table 16. Himka Pharmaceuticals Plc. Cyclophosphamide Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Himka Pharmaceuticals Plc. Recent Developments/Updates
Table 18. Amneal Pharmaceuticals LLC Basic Information, Manufacturing Base and Competitors
Table 19. Amneal Pharmaceuticals LLC Major Business
Table 20. Amneal Pharmaceuticals LLC Cyclophosphamide Drug Product and Services
Table 21. Amneal Pharmaceuticals LLC Cyclophosphamide Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Amneal Pharmaceuticals LLC Recent Developments/Updates
Table 23. NorthStar Rx LLC Basic Information, Manufacturing Base and Competitors
Table 24. NorthStar Rx LLC Major Business
Table 25. NorthStar Rx LLC Cyclophosphamide Drug Product and Services
Table 26. NorthStar Rx LLC Cyclophosphamide Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. NorthStar Rx LLC Recent Developments/Updates
Table 28. Aurobindo Pharma Ltd. Basic Information, Manufacturing Base and Competitors
Table 29. Aurobindo Pharma Ltd. Major Business
Table 30. Aurobindo Pharma Ltd. Cyclophosphamide Drug Product and Services
Table 31. Aurobindo Pharma Ltd. Cyclophosphamide Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Aurobindo Pharma Ltd. Recent Developments/Updates
Table 33. CSC Pharmaceutical International Basic Information, Manufacturing Base and Competitors
Table 34. CSC Pharmaceutical International Major Business
Table 35. CSC Pharmaceutical International Cyclophosphamide Drug Product and Services
Table 36. CSC Pharmaceutical International Cyclophosphamide Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. CSC Pharmaceutical International Recent Developments/Updates
Table 38. Jiangsu Hengrui Medicine Co Ltd Basic Information, Manufacturing Base and Competitors
Table 39. Jiangsu Hengrui Medicine Co Ltd Major Business
Table 40. Jiangsu Hengrui Medicine Co Ltd Cyclophosphamide Drug Product and Services
Table 41. Jiangsu Hengrui Medicine Co Ltd Cyclophosphamide Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Jiangsu Hengrui Medicine Co Ltd Recent Developments/Updates
Table 43. Nodus Oncology Basic Information, Manufacturing Base and Competitors
Table 44. Nodus Oncology Major Business
Table 45. Nodus Oncology Cyclophosphamide Drug Product and Services
Table 46. Nodus Oncology Cyclophosphamide Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Nodus Oncology Recent Developments/Updates
Table 48. Abbive, Inc. Basic Information, Manufacturing Base and Competitors
Table 49. Abbive, Inc. Major Business
Table 50. Abbive, Inc. Cyclophosphamide Drug Product and Services
Table 51. Abbive, Inc. Cyclophosphamide Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Abbive, Inc. Recent Developments/Updates
Table 53. Theravance Biopharm, Inc. Basic Information, Manufacturing Base and Competitors
Table 54. Theravance Biopharm, Inc. Major Business
Table 55. Theravance Biopharm, Inc. Cyclophosphamide Drug Product and Services
Table 56. Theravance Biopharm, Inc. Cyclophosphamide Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Theravance Biopharm, Inc. Recent Developments/Updates
Table 58. Sanofi S.A. Basic Information, Manufacturing Base and Competitors
Table 59. Sanofi S.A. Major Business
Table 60. Sanofi S.A. Cyclophosphamide Drug Product and Services
Table 61. Sanofi S.A. Cyclophosphamide Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Sanofi S.A. Recent Developments/Updates
Table 63. Roxane Laboratories Pvt Ltd Basic Information, Manufacturing Base and Competitors
Table 64. Roxane Laboratories Pvt Ltd Major Business
Table 65. Roxane Laboratories Pvt Ltd Cyclophosphamide Drug Product and Services
Table 66. Roxane Laboratories Pvt Ltd Cyclophosphamide Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Roxane Laboratories Pvt Ltd Recent Developments/Updates
Table 68. LGM Pharma Llc Basic Information, Manufacturing Base and Competitors
Table 69. LGM Pharma Llc Major Business
Table 70. LGM Pharma Llc Cyclophosphamide Drug Product and Services
Table 71. LGM Pharma Llc Cyclophosphamide Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. LGM Pharma Llc Recent Developments/Updates
Table 73. Global Cyclophosphamide Drug Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 74. Global Cyclophosphamide Drug Revenue by Manufacturer (2018-2023) & (USD Million)
Table 75. Global Cyclophosphamide Drug Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 76. Market Position of Manufacturers in Cyclophosphamide Drug, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 77. Head Office and Cyclophosphamide Drug Production Site of Key Manufacturer
Table 78. Cyclophosphamide Drug Market: Company Product Type Footprint
Table 79. Cyclophosphamide Drug Market: Company Product Application Footprint
Table 80. Cyclophosphamide Drug New Market Entrants and Barriers to Market Entry
Table 81. Cyclophosphamide Drug Mergers, Acquisition, Agreements, and Collaborations
Table 82. Global Cyclophosphamide Drug Sales Quantity by Region (2018-2023) & (K Units)
Table 83. Global Cyclophosphamide Drug Sales Quantity by Region (2024-2029) & (K Units)
Table 84. Global Cyclophosphamide Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 85. Global Cyclophosphamide Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 86. Global Cyclophosphamide Drug Average Price by Region (2018-2023) & (US$/Unit)
Table 87. Global Cyclophosphamide Drug Average Price by Region (2024-2029) & (US$/Unit)
Table 88. Global Cyclophosphamide Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 89. Global Cyclophosphamide Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 90. Global Cyclophosphamide Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 91. Global Cyclophosphamide Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 92. Global Cyclophosphamide Drug Average Price by Type (2018-2023) & (US$/Unit)
Table 93. Global Cyclophosphamide Drug Average Price by Type (2024-2029) & (US$/Unit)
Table 94. Global Cyclophosphamide Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 95. Global Cyclophosphamide Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 96. Global Cyclophosphamide Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 97. Global Cyclophosphamide Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 98. Global Cyclophosphamide Drug Average Price by Application (2018-2023) & (US$/Unit)
Table 99. Global Cyclophosphamide Drug Average Price by Application (2024-2029) & (US$/Unit)
Table 100. North America Cyclophosphamide Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 101. North America Cyclophosphamide Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 102. North America Cyclophosphamide Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 103. North America Cyclophosphamide Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 104. North America Cyclophosphamide Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 105. North America Cyclophosphamide Drug Sales Quantity by Country (2024-2029) & (K Units)
Table 106. North America Cyclophosphamide Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 107. North America Cyclophosphamide Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 108. Europe Cyclophosphamide Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 109. Europe Cyclophosphamide Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 110. Europe Cyclophosphamide Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 111. Europe Cyclophosphamide Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 112. Europe Cyclophosphamide Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 113. Europe Cyclophosphamide Drug Sales Quantity by Country (2024-2029) & (K Units)
Table 114. Europe Cyclophosphamide Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 115. Europe Cyclophosphamide Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 116. Asia-Pacific Cyclophosphamide Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 117. Asia-Pacific Cyclophosphamide Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 118. Asia-Pacific Cyclophosphamide Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 119. Asia-Pacific Cyclophosphamide Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 120. Asia-Pacific Cyclophosphamide Drug Sales Quantity by Region (2018-2023) & (K Units)
Table 121. Asia-Pacific Cyclophosphamide Drug Sales Quantity by Region (2024-2029) & (K Units)
Table 122. Asia-Pacific Cyclophosphamide Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 123. Asia-Pacific Cyclophosphamide Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 124. South America Cyclophosphamide Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 125. South America Cyclophosphamide Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 126. South America Cyclophosphamide Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 127. South America Cyclophosphamide Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 128. South America Cyclophosphamide Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 129. South America Cyclophosphamide Drug Sales Quantity by Country (2024-2029) & (K Units)
Table 130. South America Cyclophosphamide Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 131. South America Cyclophosphamide Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 132. Middle East & Africa Cyclophosphamide Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 133. Middle East & Africa Cyclophosphamide Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 134. Middle East & Africa Cyclophosphamide Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 135. Middle East & Africa Cyclophosphamide Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 136. Middle East & Africa Cyclophosphamide Drug Sales Quantity by Region (2018-2023) & (K Units)
Table 137. Middle East & Africa Cyclophosphamide Drug Sales Quantity by Region (2024-2029) & (K Units)
Table 138. Middle East & Africa Cyclophosphamide Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 139. Middle East & Africa Cyclophosphamide Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 140. Cyclophosphamide Drug Raw Material
Table 141. Key Manufacturers of Cyclophosphamide Drug Raw Materials
Table 142. Cyclophosphamide Drug Typical Distributors
Table 143. Cyclophosphamide Drug Typical Customers
List of Figures
Figure 1. Cyclophosphamide Drug Picture
Figure 2. Global Cyclophosphamide Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Cyclophosphamide Drug Consumption Value Market Share by Type in 2022
Figure 4. Oral Examples
Figure 5. Parenteral Examples
Figure 6. Global Cyclophosphamide Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Cyclophosphamide Drug Consumption Value Market Share by Application in 2022
Figure 8. Clinic Examples
Figure 9. Hospital Examples
Figure 10. Others Examples
Figure 11. Global Cyclophosphamide Drug Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Cyclophosphamide Drug Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Cyclophosphamide Drug Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Cyclophosphamide Drug Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Cyclophosphamide Drug Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Cyclophosphamide Drug Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Cyclophosphamide Drug by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Cyclophosphamide Drug Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Cyclophosphamide Drug Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Cyclophosphamide Drug Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Cyclophosphamide Drug Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Cyclophosphamide Drug Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Cyclophosphamide Drug Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Cyclophosphamide Drug Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Cyclophosphamide Drug Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Cyclophosphamide Drug Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Cyclophosphamide Drug Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Cyclophosphamide Drug Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Cyclophosphamide Drug Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Cyclophosphamide Drug Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Cyclophosphamide Drug Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Cyclophosphamide Drug Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Cyclophosphamide Drug Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Cyclophosphamide Drug Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Cyclophosphamide Drug Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Cyclophosphamide Drug Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Cyclophosphamide Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Cyclophosphamide Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Cyclophosphamide Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Cyclophosphamide Drug Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Cyclophosphamide Drug Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Cyclophosphamide Drug Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Cyclophosphamide Drug Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Cyclophosphamide Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Cyclophosphamide Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Cyclophosphamide Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Cyclophosphamide Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Cyclophosphamide Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Cyclophosphamide Drug Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Cyclophosphamide Drug Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Cyclophosphamide Drug Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Cyclophosphamide Drug Consumption Value Market Share by Region (2018-2029)
Figure 53. China Cyclophosphamide Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Cyclophosphamide Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Cyclophosphamide Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Cyclophosphamide Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Cyclophosphamide Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Cyclophosphamide Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Cyclophosphamide Drug Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Cyclophosphamide Drug Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Cyclophosphamide Drug Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Cyclophosphamide Drug Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Cyclophosphamide Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Cyclophosphamide Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Cyclophosphamide Drug Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Cyclophosphamide Drug Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Cyclophosphamide Drug Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Cyclophosphamide Drug Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Cyclophosphamide Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Cyclophosphamide Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Cyclophosphamide Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Cyclophosphamide Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Cyclophosphamide Drug Market Drivers
Figure 74. Cyclophosphamide Drug Market Restraints
Figure 75. Cyclophosphamide Drug Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Cyclophosphamide Drug in 2022
Figure 78. Manufacturing Process Analysis of Cyclophosphamide Drug
Figure 79. Cyclophosphamide Drug Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source